Profile data is unavailable for this security.
About the company
Renascience Inc is mainly engaged in the development and sale of pharmaceuticals and medical devices. The company is engaged in the research and development of various modalities (pharmaceuticals, medical devices, artificial intelligence (AI) solutions) to solve problems in the medical field, in collaboration with physicians. The Company is engaged in the development of drugs for four non-infectious aging-related diseases: cancer, diabetes, respiratory diseases, and cardiovascular diseases. The Company is also engaged in the solve of other medical issues such as diseases of women and children, and COVID-19 infection.
- Revenue in JPY (TTM)191.32m
- Net income in JPY-331.66m
- Incorporated2000
- Employees3.00
- LocationRenascience IncNo.401Kyodo Bldg., 2-3-6, Nihombashi Hon-choCHUO-KU 103-0023JapanJPN
- Phone+81 362620873
- Fax+81 362620973
- Websitehttps://www.renascience.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Muromachi Chemicals Inc | 6.12bn | 216.69m | 3.04bn | 205.00 | 13.90 | 1.41 | 8.66 | 0.4971 | 53.45 | 53.45 | 1,503.34 | 527.87 | 1.20 | 3.83 | 3.75 | 29,862,370.00 | 4.23 | -- | 6.84 | -- | 28.31 | -- | 3.54 | -- | 1.45 | 26.20 | 0.4483 | -- | 10.74 | -- | -43.83 | -- | -- | -- |
| D.Western Therapeutics Institute Inc | 428.36m | -812.41m | 3.37bn | 21.00 | -- | 2.64 | -- | 7.88 | -25.45 | -25.45 | 13.48 | 39.83 | 0.1607 | 0.4389 | 2.98 | 20,398,290.00 | -31.09 | -13.06 | -33.75 | -14.36 | 91.44 | 94.29 | -193.39 | -72.51 | 10.57 | -- | 0.4089 | -- | -4.40 | 7.90 | -89.07 | -- | 7.08 | -- |
| Kringle Pharma Inc | 70.58m | -865.79m | 3.74bn | 13.00 | -- | 1.53 | -- | 53.05 | -158.59 | -158.59 | 12.88 | 374.93 | 0.024 | -- | 0.7308 | 5,428,846.00 | -29.38 | -19.00 | -30.70 | -20.23 | -- | -- | -1,226.76 | -156.51 | 26.45 | -1,190.33 | 0.00 | -- | -82.33 | -- | -157.41 | -- | -- | -- |
| Human Metabolome Technologies Inc | 1.32bn | 282.64m | 3.85bn | 57.00 | 13.59 | 2.17 | 10.54 | 2.91 | 47.83 | 47.83 | 223.67 | 299.17 | 0.6302 | 14.23 | 4.74 | 23,186,330.00 | 13.48 | -- | 16.73 | -- | 65.03 | -- | 21.39 | -- | 4.27 | 151.90 | 0.1103 | -- | 6.21 | -- | 6.71 | -- | -- | -- |
| FunPep Co Ltd | 530.00k | -933.42m | 3.85bn | 15.00 | -- | 1.56 | -- | 7,262.84 | -40.11 | -40.11 | 0.0225 | 94.97 | 0.0002 | -- | -- | 35,333.33 | -34.04 | -27.10 | -35.68 | -28.75 | -- | -- | -176,116.20 | -815.82 | 25.95 | -1,765.73 | 0.00 | -- | -50.33 | -72.80 | 20.39 | -- | -13.14 | -- |
| OncoTherapy Science, Inc. | 901.22m | -1.19bn | 3.92bn | 60.00 | -- | 5.97 | -- | 4.35 | -5.77 | -5.77 | 4.36 | 3.01 | 0.7589 | 5.31 | 15.74 | 15,020,330.00 | -100.44 | -50.21 | -132.58 | -55.41 | -9.03 | -- | -132.35 | -331.97 | 3.29 | -258.18 | 0.00 | -- | -1.63 | 39.97 | 56.50 | -- | -57.92 | -- |
| Kubota Pharmaceutical Holdings Co Ltd | 39.89m | -1.49bn | 3.94bn | 12.00 | -- | 1.48 | -- | 98.80 | -26.80 | -26.80 | 0.7175 | 47.21 | 0.0107 | 0.5317 | 14.77 | 3,323,917.00 | -40.06 | -36.51 | -43.86 | -39.47 | 70.48 | -- | -3,734.55 | -13,528.87 | 10.01 | -- | 0.0512 | -- | 383.24 | -- | 26.11 | -- | 24.38 | -- |
| Perseus Proteomics Inc | 96.22m | -1.12bn | 4.24bn | 24.00 | -- | 2.64 | -- | 44.10 | -95.57 | -95.57 | 8.18 | 131.49 | 0.0424 | 1.82 | 11.22 | 4,009,083.00 | -49.52 | -33.51 | -51.65 | -34.95 | 89.01 | 93.09 | -1,168.66 | -470.63 | 17.58 | -- | 0.00 | -- | 30.96 | -20.89 | -31.38 | -- | 228.18 | -- |
| Immuno-Biological Laboratories Co., Ltd. | 788.12m | -192.71m | 4.30bn | 60.00 | -- | 3.91 | -- | 5.46 | -20.69 | -20.69 | 84.62 | 118.02 | 0.5144 | 0.8788 | 3.78 | 13,135,280.00 | -12.58 | -15.11 | -14.85 | -17.61 | 62.06 | 56.66 | -24.45 | -50.04 | 3.49 | 0.494 | 0.1774 | -- | 22.71 | 0.9405 | -11.97 | -- | -- | -- |
| BrightPath Biotherapeutics Co Ltd | 118.00k | -1.21bn | 4.39bn | 32.00 | -- | 5.20 | -- | 37,169.16 | -19.27 | -19.27 | 0.0019 | 11.92 | 0.00007 | -- | 0.0423 | 3,687.50 | -71.34 | -42.65 | -89.42 | -44.49 | -433.05 | 57.16 | -1,028,827.00 | -4,430.66 | -- | -875.45 | 0.3929 | -- | -65.73 | -56.89 | -0.0971 | -- | -56.39 | -- |
| Renascience Inc | 191.32m | -331.66m | 4.45bn | 3.00 | -- | 2.71 | -- | 23.26 | -26.09 | -26.09 | 15.05 | 129.22 | 0.0851 | -- | -- | 63,772,000.00 | -14.74 | -- | -15.49 | -- | 85.75 | -- | -173.36 | -- | -- | -- | 0.1782 | -- | -27.84 | -- | -32.05 | -- | -- | -- |
| MEDRx Co Ltd | 29.53m | -932.90m | 4.68bn | 22.00 | -- | 2.31 | -- | 158.55 | -27.24 | -27.24 | 0.8492 | 50.17 | 0.0171 | 0.2606 | 1.22 | 1,342,455.00 | -54.07 | -58.15 | -58.45 | -62.23 | 91.87 | 95.70 | -3,158.72 | -1,526.17 | 17.75 | -- | 0.00 | -- | -50.35 | 28.60 | 16.04 | -- | -55.29 | -- |
| Solasia Pharma KK | 617.00m | -1.11bn | 5.21bn | 24.00 | -- | 2.50 | -- | 8.45 | -6.61 | -6.61 | 3.67 | 10.78 | 0.2301 | 4.10 | 1.93 | 25,708,330.00 | -41.51 | -48.57 | -47.74 | -58.83 | 54.78 | 71.01 | -180.39 | -300.89 | 2.91 | -- | 0.031 | -- | -43.50 | 14.18 | 56.36 | -- | -- | -- |
| Kidswell Bio Corp | 2.62bn | -1.21bn | 5.30bn | 41.00 | -- | 3.62 | -- | 2.02 | -37.72 | -37.72 | 77.56 | 37.57 | 0.5583 | 1.26 | 4.00 | 63,807,830.00 | -25.82 | -58.77 | -36.65 | -77.44 | 50.30 | 59.87 | -46.25 | -139.31 | 1.86 | -21.98 | 0.6118 | -- | 76.92 | 21.24 | -22.83 | -- | -- | -- |
| KAINOS Laboratories, Inc. | 4.98bn | 647.70m | 5.47bn | 144.00 | 7.75 | 0.8182 | 7.09 | 1.10 | 154.88 | 154.88 | 1,192.40 | 1,466.62 | 0.605 | 2.89 | 3.13 | 34,615,160.00 | 7.86 | 6.66 | 10.25 | 9.07 | 51.41 | 51.52 | 12.99 | 9.89 | 2.53 | -- | 0.1133 | 17.01 | 6.69 | 2.33 | 10.90 | 15.37 | -46.23 | 14.87 |
| Cyfuse Biomedical KK | 61.11m | -589.21m | 5.54bn | 21.00 | -- | 1.73 | -- | 90.67 | -75.45 | -75.45 | 7.82 | 405.80 | 0.0135 | 0.5407 | 3.98 | 2,910,095.00 | -13.05 | -- | -15.34 | -- | 61.76 | -- | -964.15 | -- | 5.92 | -71.55 | 0.2218 | -- | -83.68 | -- | -24.32 | -- | -- | -- |
Data as of May 02 2024. Currency figures normalised to Renascience Inc's reporting currency: Japanese Yen JPY
0.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nikko Asset Management Co., Ltd.as of 27 Sep 2022 | 0.00 | 0.00% |
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
